Final Trades: Intuitive Surgical, Dick's Sporting Goods and Toast Inc
The Investment Committee's latest market picks.
Fiscal Year: January - December
Intuitive Surgical, Inc. (ISRG), listed on the NASDAQ, has a market capitalization of $. As of Jan 06, 2026, the stock is trading at $566.38 per share, offering investors a clear view of its current market value. Intuitive Surgical, Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 74.94, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Intuitive Surgical, Inc. also offers a dividend yield of N/A , making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that Intuitive Surgical, Inc. (ISRG) may be overvalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for Intuitive Surgical, Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Intuitive Surgical, Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Intuitive Surgical, Inc. is 88.4, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Intuitive Surgical, Inc. (ISRG) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Intuitive Surgical, Inc. (ISRG) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be overvalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Intuitive Surgical, Inc. (ISRG) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Intuitive Surgical, Inc.. To access the full SS Score, consider upgrading your subscription.
Intuitive Surgical, Inc. is a significant player in the industry sector, with a market capitalization of $ and a competitive P/E ratio of 74.94. Investors should compare these metrics with industry peers to gauge whether Intuitive Surgical, Inc. is outperforming or underperforming within its sector.
Intuitive Surgical (ISRG) stock may represent a worthwhile investment at present. Why? Because you receive high margins – indicative of pricing power and cash generation capability – at a discounted p...
Intuitive Surgical (ISRG) stock may represent a worthwhile investment at present. Why? Because you receive high margins – indicative of pricing power and cash generation capability – at a discounted p...
Robotics just delivered a breakout moment — and it's happening in Intuitive Surgical Inc (NASDAQ: ISRG), a stock already sitting deep inside the portfolios of three billionaire heavyweights.
Intuitive Surgical delivered robust Q3 results, with 23% revenue growth and a significant double beat on EPS and revenue. ISRG's valuation remains lofty, trading near fair value despite strong growth ...
Intuitive Surgical (ISRG) stock may be a solid investment at this time. Why? Because you're getting high margins – indicative of pricing power and cash generation capability – for a discounted price.
The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. Stock selection within biotechnology and health care providers & services, along with...
Baron Fifth Avenue Growth Fund gained 5.7% during the third quarter, lagging the 10.5% gain for the Russell 1000 Growth Index and the 8.1% gain for the S&P 500 Index, the Fund's benchmarks. NVIDIA rep...
GOOG was our top contributor in the quarter, benefiting from accelerating momentum in its core Search and YouTube franchises. We continue to view Alphabet as among the best-positioned secular growth f...
When it comes to surgical innovation, Intuitive Surgical (NASDAQ: ISRG) often dominates investor attention. But Insulet Corporation (NASDAQ: PODD), best known for its Omnipod insulin delivery system, ...
Intuitive Surgical (ISRG) has been on a powerful run, fueled by rising adoption of its da Vinci robotic systems and steady growth in surgical procedure volumes worldwide. The stock has outpaced both t...
Argenx SE is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of autoimmune conditions. RadNet, Inc. is the largest operator of outpatient diagno...
Intuitive Surgical is a leader at the intersection of robotics, AI, and healthcare, driving innovation with products like da Vinci 5 and Ion. ISRG's strong adoption metrics, accelerating revenue and E...
A tax charge related to its business in Brazil contributed to an earnings miss for a major video-streaming company, and its shares moved lower. Meanwhile, a provider of robotic surgical systems got a ...
Major U.S. equities indexes slid Wednesday afternoon after a flurry of weaker-than-expected earnings reports. The Dow, S&P 500, and Nasdaq all declined.
Intuitive Surgical (ISRG) delivered a standout Q3 with revenue up 23% year-over-year and EPS of $2.40, beating estimates by $0.41. Management raised 2025 margin guidance and said the tariff impact wil...
Intuitive Surgical (NASDAQ:ISRG) reported revenue of $2.51 billion for the third quarter, up 23% year-over-year, beating analyst estimates of $2.40 billion.
Intuitive Surgical (ISRG) shares jumped Wednesday after the maker of robotic surgical devices posted much better-than-expected quarterly results and raised its guidance on increased use of its units.
Diane King Hall turns to three stocks moving higher on their latest earnings. The biggest jump was seen in Intuitive Surgical (ISRG), rallying more than 15% thanks to rebounding demand in optional sur...
Shares of Intuitive Surgical jumped more than 17% in premarket trading on Wednesday after the robotic surgery pioneer reported stronger-than-expected third-quarter earnings, fuelled by the rising adop...
The maker of surgical robots installed 427 da Vinci systems in the third quarter, up from 379 last year.
Intuitive Surgical stock (NASDAQ: ISRG) experienced an impressive 17% increase in extended trading on Tuesday, October 21, 2025, after significantly exceeding investor expectations with its Q3 results...
Better-than-expected results from big banks lift S&P 500 EPS growth for Q3 2025 to 8.5%. CEOs appear confident as the earnings season kicks off, according to our latest LERI reading. Potential earning...
Intuitive Surgical, Inc. (NASDAQ:ISRG) Q3 2025 Earnings Call October 21, 2025 4:30 PM EDT Company Participants Dan Connally David Rosa - CEO & Director Jamie Samath - CFO, Head of Business Technology...
Intuitive Surgical on Tuesday reported better-than-expected third-quarter profit and revenue, driven by growing demand for its surgical robots used in minimally invasive procedures.
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2025 | 2.50B | 91.98% | Est @92.0% |
| 2026 | 3.70B | 47.91% | Analyst x5 |
| 2027 | 4.37B | 17.99% | Analyst x4 |
| 2028 | 4.83B | 10.57% | Analyst x3 |
| 2029 | 5.31B | 9.85% | Analyst x2 |
| 2030 | 5.87B | 10.59% | Analyst x2 |
| 2031 | 6.20B | 5.59% | Est @5.6% |
| 2032 | 6.48B | 4.65% | Est @4.7% |
| 2033 | 6.74B | 3.99% | Est @4.0% |
| 2034 | 6.96B | 3.29% | Est @3.3% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2023A | 749.60M | 1.00 | 749.60M |
| 2024A | 1.30B | 1.00 | 1.30B |
| 2025E | 2.50B | 1.10 | 2.27B |
| 2026E | 3.70B | 1.21 | 3.05B |
| 2027E | 4.37B | 1.34 | 3.26B |
| 2028E | 4.83B | 1.48 | 3.27B |
| 2029E | 5.31B | 1.63 | 3.26B |
| 2030E | 5.87B | 1.79 | 3.27B |
| 2031E | 6.20B | 1.98 | 3.14B |
| 2032E | 6.48B | 2.18 | 2.98B |
| 2033E | 6.74B | 2.40 | 2.81B |
| 2034E | 6.96B | 2.65 | 2.63B |
| Terminal | 92.52B | 2.65 | 34.98B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.